Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes

NCT05689684 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Lund University

Collaborators